Literature DB >> 29708229

The 340B benefit program: Why we should care about both its intentions and outcomes.

Saty Satya-Murti1.   

Abstract

Year:  2018        PMID: 29708229      PMCID: PMC5914755          DOI: 10.1212/CPJ.0000000000000445

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


× No keyword cloud information.
  6 in total

1.  Value of the 340B Drug Discount Program.

Authors:  Hagop Kantarjian; Robert Chapman
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

Review 2.  The Reach of the 340B Drug Pricing Program.

Authors:  Joerg Albrecht; Sukhraj Mudahar
Journal:  JAMA Dermatol       Date:  2015-09       Impact factor: 10.282

3.  Challenges for Managed Care from 340B Contract Pharmacies.

Authors:  Adam J Fein
Journal:  J Manag Care Spec Pharm       Date:  2016-03

4.  Consequences of the 340B Drug Pricing Program.

Authors:  Sunita Desai; J Michael McWilliams
Journal:  N Engl J Med       Date:  2018-01-24       Impact factor: 91.245

5.  Discounted Drugs for Needy Patients and Hospitals - Understanding the 340B Debate.

Authors:  Walid F Gellad; A Everette James
Journal:  N Engl J Med       Date:  2018-01-24       Impact factor: 91.245

6.  The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities.

Authors:  Rena M Conti; Peter B Bach
Journal:  Health Aff (Millwood)       Date:  2014-10       Impact factor: 6.301

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.